These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 32235654

  • 1. Effective Cellular Transport of Ortho-Halogenated Sulfonamide Derivatives of Metformin Is Related to Improved Antiproliferative Activity and Apoptosis Induction in MCF-7 Cells.
    Markowicz-Piasecka M, Komeil I, Huttunen J, Sikora J, Huttunen KM.
    Int J Mol Sci; 2020 Mar 30; 21(7):. PubMed ID: 32235654
    [Abstract] [Full Text] [Related]

  • 2. Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells.
    Markowicz-Piasecka M, Sadowski K, Huttunen J, Sikora J, Huttunen KM.
    Int J Mol Sci; 2021 May 26; 22(11):. PubMed ID: 34073245
    [Abstract] [Full Text] [Related]

  • 3. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
    Markowicz-Piasecka M, Huttunen J, Sikora J, Huttunen KM.
    Bioorg Chem; 2019 Jun 26; 87():321-334. PubMed ID: 30913467
    [Abstract] [Full Text] [Related]

  • 4. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells.
    Markowicz-Piasecka M, Huttunen J, Zajda A, Sikora J, Huttunen KM.
    Chem Biol Interact; 2022 Jan 25; 352():109795. PubMed ID: 34953865
    [Abstract] [Full Text] [Related]

  • 5. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I, Silva C, Correia-Branco A, Martel F.
    Biomed Pharmacother; 2018 Jun 25; 102():94-101. PubMed ID: 29550639
    [Abstract] [Full Text] [Related]

  • 6. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
    Cai H, Everett RS, Thakker DR.
    Br J Pharmacol; 2019 Aug 25; 176(15):2724-2735. PubMed ID: 31032880
    [Abstract] [Full Text] [Related]

  • 7. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H, Zhang Y, Han TK, Everett RS, Thakker DR.
    Int J Cancer; 2016 May 01; 138(9):2281-92. PubMed ID: 26669511
    [Abstract] [Full Text] [Related]

  • 8. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM, AboulWafa OM, Baghdadi HH, Abd El Razik HA, Sedra SMY, Shamaa MM.
    Bioorg Chem; 2021 Oct 01; 115():105208. PubMed ID: 34365057
    [Abstract] [Full Text] [Related]

  • 9. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells.
    Queiroz EA, Puukila S, Eichler R, Sampaio SC, Forsyth HL, Lees SJ, Barbosa AM, Dekker RF, Fortes ZB, Khaper N.
    PLoS One; 2014 Oct 01; 9(5):e98207. PubMed ID: 24858012
    [Abstract] [Full Text] [Related]

  • 10. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S, Mavrova AT, Yancheva D, Nikolova B, Tsoneva I.
    Anticancer Agents Med Chem; 2021 Oct 01; 21(11):1441-1450. PubMed ID: 32698751
    [Abstract] [Full Text] [Related]

  • 11. The Effect of a Ferrocene Containing Camphor Sulfonamide DK-164 on Breast Cancer Cell Lines.
    Schröder M, Yusein-Myashkova S, Petrova M, Dobrikov G, Kamenova-Nacheva M, Todorova J, Pasheva E, Ugrinova I.
    Anticancer Agents Med Chem; 2019 Oct 01; 19(15):1874-1886. PubMed ID: 31339077
    [Abstract] [Full Text] [Related]

  • 12. Novel halogenated sulfonamide biguanides with anti-coagulation properties.
    Markowicz-Piasecka M, Sikora J, Zajda A, Huttunen KM.
    Bioorg Chem; 2020 Jan 01; 94():103444. PubMed ID: 31776031
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and Structure-Activity Relationship Studies of Novel Aryl Sulfonamides and Their Activity against Human Breast Cancer Cell Lines.
    Azevedo-Barbosa H, Ferreira-Silva GÁ, do Vale BP, Hawkes JA, Ionta M, Carvalho DT.
    Chem Biodivers; 2022 Dec 01; 19(12):e202200831. PubMed ID: 36305872
    [Abstract] [Full Text] [Related]

  • 14. Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study.
    Bardaweel SK, Alsalamat HA, Aleidi SM, Bashatwah RM.
    Acta Pharm; 2018 Dec 01; 68(4):517-524. PubMed ID: 31259708
    [Abstract] [Full Text] [Related]

  • 15. Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution.
    Fatehi R, Rashedinia M, Akbarizadeh AR, Zamani M, Firouzabadi N.
    Biochem Biophys Res Commun; 2023 Feb 12; 644():130-139. PubMed ID: 36641965
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA, Alqudah MA, Audat SA, Al-Balas QA, El-Elimat T, Hassan MA, Frhat IN, Azaizeh MM.
    Drug Des Devel Ther; 2019 Feb 12; 13():423-433. PubMed ID: 30774307
    [Abstract] [Full Text] [Related]

  • 17. Effects of metformin on cell kinetic parameters of MCF-7 breast cancer cells in vitro.
    Topcul M, Cetin I.
    Asian Pac J Cancer Prev; 2015 Feb 12; 16(6):2351-4. PubMed ID: 25824763
    [Abstract] [Full Text] [Related]

  • 18. New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation.
    Tomorowicz Ł, Żołnowska B, Szafrański K, Chojnacki J, Konopiński R, Grzybowska EA, Sławiński J, Kawiak A.
    Int J Mol Sci; 2022 Jun 28; 23(13):. PubMed ID: 35806186
    [Abstract] [Full Text] [Related]

  • 19. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
    Abdel-Mohsen HT, El Kerdawy AM, Omar MA, Petreni A, Allam RM, El Diwani HI, Supuran CT.
    Eur J Med Chem; 2022 Jan 15; 228():114004. PubMed ID: 34847409
    [Abstract] [Full Text] [Related]

  • 20. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
    Mohamed HS, Abdelgawad MA, Hegab M, Hamza ZS, Nagdy AM, Ahmed SA, Ahmed OM, Ghoneim MM.
    Curr Org Synth; 2023 Jan 15; 20(3):339-350. PubMed ID: 36214306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.